Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Abbott Laboratories NYSE:ABT Sees Increase in Institutional Shareholders Yahoo Finance

November 28, 2024
Abbott Laboratories, a leading pharmaceutical company listed on the NYSE under the ticker symbol ABT, has seen a significant increase in institutional shareholders. According to Yahoo Finance, 78% of the company is now controlled by these institutional investors, indicating a strong interest in the company's potential for growth and profitability.

In related news, global banking giant BNP Paribas has recently decreased its stake in Abbott Laboratories. The French multinational bank has sold off a portion of its shares, suggesting a strategic decision to reallocate its resources.

However, despite the decrease in stake by BNP Paribas, Abbott Laboratories has attracted the attention of other investment firms. Prospector Partners LLC, a renowned investment management firm, has recently purchased shares of the company. This move indicates their confidence in Abbott Laboratories and its ability to deliver strong returns to shareholders.

On the other hand, Raymond James Trust N.A., a well-known trust company, has recently sold 5,886 shares of Abbott Laboratories. While the reason behind this sale is unknown, it is important to note that the overall institutional ownership of the company remains strong.

Investors interested in the future prospects of Abbott Laboratories are advised to seek professional advice from experts in the field. Stocks Prognosis, a trusted resource for stock market analysis, recommends investors to consider the forecast of the company's stock movement before making any investment decisions.

With a strong presence in the pharmaceutical industry and the backing of institutional shareholders, Abbott Laboratories continues to be a company to watch. As it navigates the evolving landscape of healthcare, its dedication to innovation and commitment to delivering quality products have positioned it for future success.
If you want to leave a comment, then you need Login or Register





Other data for ABT

Related data

ABTJune 5, 2025Abbott Laboratories ABT is Attracting Investor Attention: Here is What You Should Know  ~1 min.

Abbott Laboratories (ABT) has been making waves in the healthcare sector, attracting attention from investors around the globe....

ABTMarch 18, 2025Abbott Laboratories Continues to Drive Growth in the Healthcare Sector  ~2 min.

Abbott Laboratories (ABT) has emerged as a top player in the healthcare industry, making it an attractive stock for long-term investors....

ABTMarch 17, 2025Abbott Laboratories: A Leader in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) is a renowned healthcare company that has caught the attention of investors and industry experts alike....

ABTMarch 16, 2025Abbott Laboratories: Breaking New Ground in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making waves in the healthcare industry with its groundbreaking innovations....

ABTMarch 15, 2025Abbott Laboratories: A Healthcare Stock With Long-Term Investment Potential  ~2 min.

Abbott Laboratories (NYSE:ABT) is a renowned healthcare company that has been delivering groundbreaking medical technologies and products for decades....

ABTFebruary 26, 2025Abbott Laboratories Continues to Deliver Strong Earnings Growth  ~2 min.

Abbott Laboratories, a leading global healthcare company, has reported steady growth in earnings over the past five years....

ABTFebruary 22, 2025Abbott Laboratories: A Rising Star in the Pharmaceutical Industry  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making significant progress in the pharmaceutical industry, positioning itself as one of the best drug stocks to buy now....

ABTFebruary 21, 2025Abbott Laboratories NYSE:ABT: A Leading Drug Stock with Promising Future  ~1 min.

Abbott Laboratories, a renowned pharmaceutical company, has emerged as one of the best drug stocks to invest in....

ABTFebruary 21, 2025ABBOTT LABORATORIES Stock Hits Price Target with 16.11% Profit: QuantWave Forecast Success  ~2 min.

On December 2, 2024, QuantWave, the automated forecasting platform, issued a long signal for ABBOTT LABORATORIES stock when it was trading at 115.66 $....

ABTFebruary 21, 2025ABBOTT LABORATORIES Hits Price Target Forecast with 17.43% Profit  ~1 min.

On December 10, 2024, QuantWave, an automated forecasting platform, issued a long signal for ABBOTT LABORATORIES stock when it was priced at 113.86 $....

ABTNovember 28, 2024Abbott Laboratories Sees Increased Institutional Shareholder Ownership  ~2 min.

Abbott Laboratories, a leading healthcare company, has reported a significant increase in institutional shareholder ownership....

ABTNovember 27, 2024Abbott Laboratories ABT: Breakthrough Research Leads to Potential Game-Changing Drug  ~2 min.

A recent breakthrough in research by Abbott Laboratories has led to the discovery of a potential game-changing drug....

ABTNovember 29, 2024Abbott Laboratories: Institutional Shareholders Control 78% of the Company  ~1 min.

According to Yahoo Finance, institutional shareholders have a significant stake in Abbott Laboratories NYSE:ABT, owning 78% of the company....

ABTJanuary 1, 2025Abbott Laboratories: The Rise of Institutional Shareholders  ~2 min.

Abbott Laboratories, a renowned healthcare company listed on NYSE under the ticker symbol ABT, has been attracting the attention of institutional shareholders....

ABTDecember 31, 2024Investors Eyeing Abbott Laboratories NYSE:ABT as Institutional Shareholders Maintain Control  ~1 min.

Abbott Laboratories, a leading healthcare company listed on NYSE under the ticker ABT, has drawn attention from investors due to its majority ownership by institutional shareholders....